Editsprings@163.com (周一至周日,9:00-23:00) | (周一至周日,9:00-23:00)

医学翻译肿瘤分期系统,EditSprings,艾德思

网络 | 2019/01/03 14:40:05  | 179 次浏览

 原文: Compared with traditional urothelial tumors, which arise from surface epithelium and grow outward, urachal tumors arise in the muscle wall or externally to the bladder and grow inward. Thus, the traditional staging system used for urothelial tumors does not apply. A broad staging system was initially proposed by Sheldon (BOX 2). Unfortunately, most patients present at stage III or higher, probably due to lack of symptoms, which may not develop until tumors are larger or have invaded through the muscle wall and surface epithelium sufficiently for recurrent gross hematuria to raise the alarm. Recently, investigators at the Mayo Clinic (MN, USA) proposed an alternative, more simplistic staging system: Stage I, confined to urachus bladder; Stage II, beyond urachus/bladder; Stage III, regional lymph nodes; and Stage IV, distant lymph nodes/metastases. However, the distinction between stage III and IV of the Mayo system seems somewhat artificial since there is no difference in survival when comparing patients with localized lymph nodes and distant metastases. Previously published data from MDACC also suggest similar survival of approximately 2 years when comparing lymph node metastases with distant metastases. Unfortunately, with only limited numbers of patients with urachal cancer, neither staging system can be validated easily.

译文: 与传统尿路上皮肿瘤相比(产生于表面上皮并向外生长),脐尿管肿瘤起始于肌肉壁或膀胱外,向内生长.因此,用于尿路上皮肿瘤的传统分期方式不再适用.最初由Sheldon提出一个宽泛的分期系统(表2).遗憾的是,多数处于III期或更晚期的患者可能由于缺乏症状,直到肿瘤变大或充分穿透肌肉壁和表面上皮,并出现血尿症状. 最近,美国明尼苏达州的梅奥诊所(Mayo Clinic)提出另一个更为简单的分期系统:I期,限于脐尿管及膀胱内;II期,超出脐尿管/膀胱;III期,局部淋巴结;IV期,远端淋巴结/转移.然而,梅奥系统对于III期和IV期的划分似乎有些人为化,因为局部淋巴结和远端转移的患者相比并没有生存差异.之前从安德森癌症中心(MDACC)发布的数据也提示,淋巴结转移和远端转移患者相比情况类似,即具有约2年的生存时间.遗憾的是,脐尿管癌患者数量极为有限,因而没有一种确切的分期系统.

 

 

更多科研论文服务,动动手指,请戳 论文润色投稿期刊推荐论文翻译润色论文指导及修改论文预审

语言不过关被拒?美国EditSprings--专业英语论文润色翻译修改服务专家帮您!

上一篇:【严正申明】关于我公司网站被恶意抄袭严正声明

下一篇:2018年度SCI期刊润色黑马机构,EditSprings,艾德思

特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。

凡注明来源为“EditSprings”的论文,如需转载,请注明来源EditSprings并附上论文链接。

最热论文